Utilization of Cefiderocol in a Case of Extensively Drug-Resistant Klebsiella pneumoniae Prostatitis and Recurrent Urinary Tract Infection.
Key Points
The aim is to investigate the effectiveness of cefiderocol in treating extensively drug-resistant Klebsiella pneumoniae prostatitis and urinary tract infections.
Evaluated cefiderocol's clinical outcomes in a case of prostatitis.
Monitored prostate penetration of cefiderocol.
Collected data on recurrent urinary tract infections.
Cefiderocol successfully treated prostatitis caused by extensively drug-resistant Klebsiella pneumoniae.
Significant reduction in recurrent urinary tract infections was observed.
Abstract
prostatitis, though additional research is required to fully understand its prostate penetration and clinical outcomes.